Galvecta Plus 50/1000mg Tablets – Vildagliptin+Metformin HCl

Brand Name: ?

Generic Name: Vildagliptin + Metformin HCl

Dosage Strength: 50mg Vildagliptin + 1000mg Metformin HCl

Manufacturer: Pharmaceutical (Pvt) Ltd.

Packing: 14 Tablets

Description and Usage:

Galvecta Plus (Vildagliptin+Metformin HCl) 50/1000mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.

Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.

Category: Diabetes Drugs

Description
Reviews (0)

Description

In the relentless pursuit of managing type 2 diabetes effectively, pharmaceutical innovations continually reshape treatment paradigms.

Galvecta Plus 50/1000mg Tablets emerge as a beacon of hope, amalgamating the therapeutic prowess of Vildagliptin and Metformin Hydrochloride (HCl) into a single formulation.

Let’s delve into the nuances of this groundbreaking medication and its potential impact on diabetes management.

Understanding Type 2 Diabetes:

Type 2 diabetes manifests as a chronic metabolic disorder characterized by insulin resistance and impaired insulin secretion, resulting in elevated blood sugar levels.

Timely intervention is essential to mitigate complications and improve patients’ quality of life.

Exploring the Components:

Vildagliptin:

Belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class, Vildagliptin enhances insulin secretion while suppressing glucagon release, fostering glycemic control.

Metformin HCl:

A cornerstone in diabetes therapy, Metformin HCl reduces hepatic glucose production, enhances insulin sensitivity, and retards intestinal glucose absorption.

The Synergy Unleashed:

The fusion of Vildagliptin and Metformin HCl in Galvecta Plus tablets offers a myriad of benefits:

Holistic Glycemic Management:

Targeting multiple facets of glucose regulation ensures comprehensive blood sugar control, thereby reducing the risk of diabetes-related complications.

Side Effect Mitigation:

By leveraging lower individual doses, adverse effects are minimized, enhancing treatment tolerability and patient adherence.

Enhanced Convenience:

Consolidating two potent medications into a single tablet streamlines the treatment regimen, fostering patient compliance and facilitating ease of administration.

Dosage and Considerations:

Galvecta Plus 50/1000mg Tablets typically contain 50mg of Vildagliptin and 1000mg of Metformin HCl.

Individual dosage adjustments may be warranted based on patient response and medical history, necessitating close monitoring by healthcare providers.

Safety and Precautions:

While generally well-tolerated, potential side effects may include gastrointestinal disturbances and, rarely, lactic acidosis.

Patients with renal or hepatic impairment necessitate meticulous monitoring and dose adjustment.

Conclusion:

Galvecta Plus 50/1000mg Tablets epitomize a significant stride in type 2 diabetes management, merging Vildagliptin and Metformin HCl to deliver enhanced efficacy and convenience.

However, prudent utilization under medical supervision remains imperative to optimize treatment outcomes and ensure patient well-being.

Buy: Inosita Plus XR (Sitagliptin+Metformin HCl) 100/1000mg Tablets

Reviews

There are no reviews yet.

Be the first to review “Galvecta Plus 50/1000mg Tablets – Vildagliptin+Metformin HCl”